HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A new modified bovine heterograft for vascular access in haemophiliacs.

Abstract
Because of poor venous access and failure of previous arteriovenous shunts due to thrombosis, two patients with severe coagulapathies had an arteriovenous fistula performed using a new chemically treated bovine carotid artery segment (Solcograft-P). To date, no complications have been noted after 16 and 17 months respectively. This treated heterograft maintains many of the physical characteristics observed in a normal bovine carotid artery. The theoretical advantages for using this heterograft in such patients are discussed.
AuthorsN C West, R Sells, Y Korn, B A McVerry
JournalClinical and laboratory haematology (Clin Lab Haematol) Vol. 6 Issue 4 Pg. 375-7 ( 1984) ISSN: 0141-9854 [Print] England
PMID6525805 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Arteriovenous Shunt, Surgical (methods)
  • Bioprosthesis
  • Blood Vessel Prosthesis
  • Hemophilia A
  • Humans
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: